BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 27581271)

  • 1. Progress in the care of familial hypercholesterolaemia: 2016.
    Bell DA; Watts GF
    Med J Aust; 2016 Sep; 205(5):232-6. PubMed ID: 27581271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the detection of familial hypercholesterolaemia.
    Lan NSR; Martin AC; Brett T; Watts GF; Bell DA
    Pathology; 2019 Feb; 51(2):213-221. PubMed ID: 30579649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy).
    Descamps OS; Van Caenegem O; Hermans MP; Balligand JL; Beauloye C; Bondue A; Carlier S; Castermans E; Chenot F; Claeys M; De Block C; de Leener A; De Meester A; Demeure F; De Raedt H; Desmet W; Elegeert I; Guillaume M; Hoffer E; Kacenelenbogen R; Lancellotti P; Langlois M; Leone A; Mertens A; Paquot N; Vanakker O; Vanoverschelde JL; Verhaegen A; Vermeersch P; Wallemacq C; Rietzschel E;
    Atherosclerosis; 2018 Oct; 277():369-376. PubMed ID: 30270073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
    Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF
    Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9.
    Page MM; Stefanutti C; Sniderman A; Watts GF
    Clin Sci (Lond); 2015 Jul; 129(1):63-79. PubMed ID: 25881720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.
    Wiegman A; Gidding SS; Watts GF; Chapman MJ; Ginsberg HN; Cuchel M; Ose L; Averna M; Boileau C; Borén J; Bruckert E; Catapano AL; Defesche JC; Descamps OS; Hegele RA; Hovingh GK; Humphries SE; Kovanen PT; Kuivenhoven JA; Masana L; Nordestgaard BG; Pajukanta P; Parhofer KG; Raal FJ; Ray KK; Santos RD; Stalenhoef AF; Steinhagen-Thiessen E; Stroes ES; Taskinen MR; Tybjærg-Hansen A; Wiklund O;
    Eur Heart J; 2015 Sep; 36(36):2425-37. PubMed ID: 26009596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parent-child genetic testing for familial hypercholesterolaemia in an Australian context.
    Pang J; Martin AC; Bates TR; Hooper AJ; Bell DA; Burnett JR; Norman R; Watts GF
    J Paediatr Child Health; 2018 Jul; 54(7):741-747. PubMed ID: 29626384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
    Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
    Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New data on familial hypercholesterolaemia and acute coronary syndromes: The promise of PCSK9 monoclonal antibodies in the light of recent clinical trials.
    Ellis KL; Pang J; Schultz CJ; Watts GF
    Eur J Prev Cardiol; 2017 Jul; 24(11):1200-1205. PubMed ID: 28482694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunistic screening for familial hypercholesterolaemia via a community laboratory.
    Bell DA; Hooper AJ; Bender R; McMahon J; Edwards G; van Bockxmeer FM; Watts GF; Burnett JR
    Ann Clin Biochem; 2012 Nov; 49(Pt 6):534-7. PubMed ID: 23002132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting familial hypercholesterolaemia in the community: impact of a telephone call from a chemical pathologist to the requesting general practitioner.
    Bell DA; Hooper AJ; Edwards G; Southwell L; Pang J; van Bockxmeer FM; Watts GF; Burnett JR
    Atherosclerosis; 2014 Jun; 234(2):469-72. PubMed ID: 24814411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing a national screening programme for familial hypercholesterolaemia in Lithuania.
    Petrulioniene Z; Gargalskaite U; Kutkiene S; Staigyte J; Cerkauskiene R; Laucevicius A
    Atherosclerosis; 2018 Oct; 277():407-412. PubMed ID: 30270078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
    Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T
    Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.
    Nordestgaard BG; Chapman MJ; Humphries SE; Ginsberg HN; Masana L; Descamps OS; Wiklund O; Hegele RA; Raal FJ; Defesche JC; Wiegman A; Santos RD; Watts GF; Parhofer KG; Hovingh GK; Kovanen PT; Boileau C; Averna M; Borén J; Bruckert E; Catapano AL; Kuivenhoven JA; Pajukanta P; Ray K; Stalenhoef AF; Stroes E; Taskinen MR; Tybjærg-Hansen A;
    Eur Heart J; 2013 Dec; 34(45):3478-90a. PubMed ID: 23956253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC).
    Futema M; Cooper JA; Charakida M; Boustred C; Sattar N; Deanfield J; Lawlor DA; Timpson NJ; ; Humphries SE; Hingorani AD
    Atherosclerosis; 2017 May; 260():47-55. PubMed ID: 28349888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. My Approach to the Patient With Familial Hypercholesterolemia.
    Safarova MS; Kullo IJ
    Mayo Clin Proc; 2016 Jun; 91(6):770-86. PubMed ID: 27261867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Familial Hypercholesterolemia in Hong Kong.
    Hu M; Hooper AJ; Bockxmeer FM; Watts GF; Chan JC; Tomlinson B
    J Atheroscler Thromb; 2016 May; 23(5):520-31. PubMed ID: 26875521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Algorithm for detection and screening of familial hypercholesterolemia in Lithuanian population.
    Aliosaitiene U; Petrulioniene Z; Rinkuniene E; Mainelis A; Brazdziuniene E; Smailyte U; Sileikiene V; Laucevicius A
    Lipids Health Dis; 2024 May; 23(1):136. PubMed ID: 38715054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond early LDL cholesterol lowering to prevent coronary atherosclerosis in familial hypercholesterolaemia.
    Ibrahim S; Reeskamp LF; de Goeij JN; Hovingh GK; Planken RN; Bax WA; Min JK; Earls JP; Knaapen P; Wiegman A; Stroes ESG; Nurmohamed NS
    Eur J Prev Cardiol; 2024 May; 31(7):892-900. PubMed ID: 38243822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.